Open access
Oct 2026
Clinical efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII in long-term prophylaxis study in patients older than 6 years with severe von Willebrand disease
Prophylactic treatment using a plasma-derived von Willebrand factor (pdVWF, Wilfactin®) was safe and effective in clinically severe VWD.
Cédric Hermans, B. Meddeb, Q. Van Thillo et al.
· Therapeutic Advances in Hema... · 0 citations